Experiences with Tolbutamide

This page shows detailed information about a drug such as statistics, patient reviews and related articles.

Active ingredient: Tolbutamide
ATC Code: A10BB03

Level of
Satisfaction

Level of Satisfaction 50%

What patients say...

Effectiveness 50%
Quantity of side effects 37%
Severity of side effects 25%
Ease of use 37%

Our patients

Our patients, demographics

Read our patient's reviews about Tolbutamide

Filter reviews by...

hide filters...
translation feature available for reviews from other countries
Tolbutamide
10/8/2017 | | 52moderated by Henry
Tolbutamide (500mg) for diabetes type 2

Definitely not a good experience, rapid change in blood sugars, go from hyper to hypo in minutes, bowel cramps, fatigue, insomnia, not a good drug in my experience.
> read full review...

Tolbutamide
1/20/2016 | | 70moderated by Charlotte
Tolbutamide (500mg) for diabetes type 2

Since I initially started taking tolbutamide at 500 mg a day then from September 2013, 1000 mg a day, the only side effect I seem to have is weight gain. But because I take so many other medicines including a daily 5 mg maintenance dose of prednisone , I don't know if this is actually to do with the tolbutamide or to do with the interaction between my many medicines. My immunologist advised me ...
> read full review...

Most reviewed drugs


The content on this page is user-generated content, read and revised before approval to comply with our standards for a drug review or reaction. We do not enforce any proven medical knowledge from our users to allow them to present their experiences. This way, the opinions and experiences described state only the views of the writers and not those of the owner of this website. Remember that these experiences differ from person to person and that you should always contact your doctor or pharmacist for advice on medication.

Copyright © 2008-2024 Insight Pharma Services BV.
All rights reserved.
Most icons from FontAwesome. Some icons made by Prosymbols from www.flaticon.com and licensed as CC 3.0 BY.